Creative Planning
IMNM icon

Creative Planning’s Immunome IMNM Stock Holding History

Creative Planning’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$558K Buy
25,518
+4,637
+22% +$103K ﹤0.01% 2948
2025
Q4 		$449K Buy
20,881
+2,217
+12% +$38.9K ﹤0.01% 2934
2025
Q3 		$219K Buy
18,664
+710
+4% +$7.06K ﹤0.01% 3394
2025
Q2 		$167K Buy
+17,954
New +$147K ﹤0.01% 3293
2025
Q1 		– Sell
-233
Closed -$2.47K – 3593
2024
Q4 		$2.47K Buy
+233
New +$2.82K ﹤0.01% 3449

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Creative Planning's IMNM Position: Q1 2026 in Review

Creative Planning increased its Immunome (IMNM) stake by 22% in Q1 2026, buying an estimated $103K and bringing the position to 25,518 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #2948.

Creative Planning first reported a position in IMNM in Q4 2024 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Creative Planning held 25,518 shares of Immunome worth $558K as of Q1 2026.
  • Creative Planning bought 4,637 Immunome shares in Q1 2026, an estimated $103K.
  • Immunome made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #2948 holding.
  • Creative Planning first reported a position in Immunome in Q4 2024 and has held it in 5 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.